Hello! You are part of a community of millions who seek out Democracy Now! for ad-free daily news you can trust. Maybe you come for our daily headlines. Maybe you come for our in-depth stories that expose corporate and government abuses of power and lift up the voices of ordinary people working to make change in extraordinary times. We produce all of this news at a fraction of the budget of a commercial news operation. We do this without ads, government funding or corporate sponsorship. How? This model of news depends on support from viewers and listeners like you. Today, less than 1% of our visitors support Democracy Now! with a donation each year. If even 3% of our website visitors donated just $12 per month, we could cover our basic operating expenses for a year. Pretty amazing right? If you visit us daily or weekly or even just once a month, now is a great time to make a monthly contribution.

Your Donation: $

Friday, February 6, 2004

  • Dean Talks to Democracy Now! on War, His Future, the Media & Washington Insiders


    Presidential candidate Howard Dean speaks to us from Wisconsin, the state where he admitted yesterday he must win in order to keep running. Although he raised over $40 million in fundraising, Dean’s campaign is faltering after he failed to finish better than second in the first seven races. [includes transcript]

  • CIA’s Tenet: Iraq Posed No Imminent Threat; Hunt for WMD Must Go On


    Former CIA analyst Melvin Goodman and Mother Jones reporter Robert Dreyfuss discuss George Tenet’s speech and examine the role of the Pentagon’s secretive Office of Special Plans in the lead-up to the invasion of Iraq. [includes transcript]

  • NYPD Pays $27M to Black & Latino Officers To Settle Discrimination Suit


    A groundbreaking settlement has been reached in a 1999 lawsuit in which nearly four-dozen cops argued that their working conditions were hostile; that they were more severely punished than white officers in cases of disciplinary action; and they faced retaliation if they challenged their treatment.